| This week's sponsor is Premier Research. | | | 6 Considerations When Designing Hematology Clinical Trials
Researchers are turning a corner in treating and curing blood disorders. Download our paper for 6 dosing and safety considerations for developing early-phase trials. Premier Research. It's what we do. Best. |
Today's Rundown Johnson & Johnson’s JLABS looks east as it lands in Shanghai Special Report—2017’s fiercest women in life sciences Revance’s rival to Allergan’s Botox aces phase 3 Goldfinch poaches AstraZeneca research exec Tony Johnson for CEO Cellectis lures ex-Servier cancer R&D chief back to industry Ironwood's diabetes drug posts positive phase 2 data, but shares still dip Bioclinica lifts imaging and eHealth chief Herron to CEO, launches clinical adjudication service LivaNova inks $225M deal for sleep apnea startup Featured Story | | | Tuesday, December 5, 2017 Now well established across the U.S. and Canada, J&J’s biotech incubator system has expanded into Asia with its first center in China. |
|
|
| This week's sponsor is Precision Oncology. | | | What's hot at ASH? Accelerated approvals. Get the POV.
New cancer therapies are getting approved in less time, with fewer patients. How is this possible? Download our free Pre-ASH POV to find out and visit Precision Oncology at ASH Booth 2540. |
Top Stories Tuesday, December 5, 2017 It feels as though we say this every year, but it bears repeating: From CEOs and COOs to division chiefs and venture capital partners, women are taking the lead and making an impact all over the life sciences industry. Tuesday, December 5, 2017 A pair of phase 3 trials of Revance’s RT002 have hit all their primary and secondary endpoints. The data show the effect of the neuromodulator on wrinkles lasted for six months, suggesting it poses a threat to Allergan’s blockbuster Botox franchise. Tuesday, December 5, 2017 The lure of a razor-sharp therapeutic focus has enticed AstraZeneca’s head of early clinical development, Tony Johnson, to take the top job at kidney disease specialist Goldfinch Bio. Tuesday, December 5, 2017 Cellectis has named Stéphane Depil, M.D., Ph.D., as its CMO and senior vice president of R&D. The appointment sees the former director of oncology R&D at Servier return to the industry after a spell directing the cancer immunotherapy program at a cancer center in Lyon. Tuesday, December 5, 2017 Ironwood Pharmaceuticals unveiled promising topline data from a pair of phase 2a trials investigating its sGC stimulator in patients with Type 2 diabetes and hypertension. Tuesday, December 5, 2017 Bioclinica named current imaging and eHealth president David Herron to succeed retiring John Hubbard, Ph.D., as CEO, and launched a cloud-based clinical adjudication platform grown out of its recent acquisition of MDDX. Tuesday, December 5, 2017 LivaNova has struck a $225 million deal to buy ImThera Medical. The agreement will see LivaNova hand over $78 million upfront and commit to almost $150 million in regulatory and sales milestones to acquire the rest of ImThera and its neurostimulation treatment for sleep apnea. Resources Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Deloitte Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Sponsored by: Veeva Systems Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Sponsored by: Veeva Systems See the results from one of the largest, most in-depth surveys of clinical data management professionals on data management practices, performance, and challenges. Sponsored by: Veeva Systems Gain a complete, real-time view of quality and streamline operations. Incorporate partners into processes for critical oversight and 30% greater efficiency, and transform cross-functional processes like change control. Presented by: DSM Biomedical Discover DSM's Dyneema Purity® membrane, an effective and efficient material to construct stent grafts used in minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases. Sponsored by: ePharmaSolutions As clinical trials become more complex, safety document distribution to investigative sites has reached the point that demands a solution. Sponsored by: Ashfield Healthcare December 5, 2017 | 2pm EST / 11am PST Join this webinar to learn methods that maintain and build sales momentum despite turnover. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. FierceBiotech Executive Breakfast: Get Good Science and the Money will Follow January 9, 2018 | San Francisco, CA BIO CEO & Investor Conference February 12-13, 2018 | New York, New York | 